Biomarkers and treatments for heart failure
US10100363B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 12, 2016 |
| Grant date | Oct 16, 2018 |
| Priority date | — |
| Expiry date | Oct 12, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention features methods to predict the response to a cardiac therapy in a patient suffering from a cardiac disease, e.g., heart failure. The invention features measurement expression of biomarkers that help in this prediction. The invention also features methods for treatment of cardiac diseases. These methods include cardiac resynchronization therapy and miRNA based therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.